| The optimal antithrombotic regimen in patients with atrial fibrillation after a percutaneous coronary intervention has not been settled. |
| Our meta-analysis compared the efficacy and safety of potent oral P2Y12 inhibitors versus clopidogrel. |
| Potent P2Y12 inhibitors increase bleeding risk, without any measured reduction of ischemic events. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.